GovChime
Notice ID: ec17a44e13b34911bccab27284e1f023Special Notice

Chemistry and Special Chemistry testing

Archived on December 26, 2023. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
12:00 PM UTC−06:00
Posted
November 30, 2023
Notice type
Special Notice
NAICS
325413: In-Vitro Diagnostic Substance Manufacturing
Agency
Department of WarDEFENSE HEALTH AGENCY (DHA)

Notice details

Office
DEFENSE HEALTH AGENCY
Place of performance
Biloxi, MS, 39534
Last updated
Dec 4, 2025

Identifiers

Solicitation number
HT940824R0001
Notice ID
ec17a44e13b34911bccab27284e1f023

Description

The Southern Markets Contracting Division (SMCD), San Antonio, Texas, intends to award a firm-fixed-price (FFP) sole source contract to Siemens Healthcare Diagnostics of Tarrytown, New York to conduct Chemistry and Special Chemistry testing for Keesler Medical Center, Keesler Air Force Base, Mississippi. As a Cost-per-Reportable-Test (CPRT) vehicle, the contractor also provides all equipment, consumables, and services necessary to perform the required testing. The contract will be awarded under the authority of Federal Acquisition Regulation (FAR) 13.501. The applicable NAICS code for this requirement is 325413, In-Vitro Diagnostics Substance Manufacturing. The Small Business Size Standard is 1,250 employees. Siemens Healthcare Diagnostics is an "other-than-small business." The contract will be awarded on or before 1 January 2024. NOTE: This contract will be issued for a performance period of 1 January 2024 -30 September 2024, with one (1) twelve-month option period. The Government intends to issue a competitive solicitation on a full-and-open basis for these tests, with full performance on the resultant contract to start in FY 2026. This notice is not a request for competitive quotes. All responsible sources may submit a capability statement, which shall be considered by the agency before the intended award date to determine if any other entity is capable of performing the required testing. Interested sources who submit data are responsible for appropriately marking information if it is proprietary in nature. In order for the Government to consider another source, the capability statement must demonstrate the source's ability to 1) provide the required testing; 2) deliver, install, and validate the analyzer(s) to ensure patient-ready testing; and 3) ability to connect to the Defense Health Agency/Military Health System network. The Government shall not reimburse interested sources for any information provided. No requests for capability briefings will be honored as a result of this notice and any information provided will not be used as part of any subsequent solicitation requirement. No telephonic inquires will be honored. A determination by the Government not to compete with this proposed contract based upon responses to this notice is solely within the discretion of the Government. NOTE: INTERESTED VENDORS MUST RESPOND TO THIS NOTICE TO THE BELOW POCs ON OR BEFORE 11 DECEMBER 2023 BY NOON CENTRAL TIME IN ORDER TO BE CONSIDERED.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:HT940824R0001
  1. Special NoticeCurrentNov 30, 2023

    Chemistry and Special Chemistry testing

    Notice ec17a44e13b34911bccab27284e1f023 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

HT940824R0001

Archive Date

Dec 26, 2023

Office Address

SAN ANTONIO, TX, 78230